Correlation Between Cingulate Warrants and Enliven Therapeutics
Can any of the company-specific risk be diversified away by investing in both Cingulate Warrants and Enliven Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cingulate Warrants and Enliven Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cingulate Warrants and Enliven Therapeutics, you can compare the effects of market volatilities on Cingulate Warrants and Enliven Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cingulate Warrants with a short position of Enliven Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cingulate Warrants and Enliven Therapeutics.
Diversification Opportunities for Cingulate Warrants and Enliven Therapeutics
-0.36 | Correlation Coefficient |
Very good diversification
The 3 months correlation between Cingulate and Enliven is -0.36. Overlapping area represents the amount of risk that can be diversified away by holding Cingulate Warrants and Enliven Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Enliven Therapeutics and Cingulate Warrants is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cingulate Warrants are associated (or correlated) with Enliven Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Enliven Therapeutics has no effect on the direction of Cingulate Warrants i.e., Cingulate Warrants and Enliven Therapeutics go up and down completely randomly.
Pair Corralation between Cingulate Warrants and Enliven Therapeutics
Assuming the 90 days horizon Cingulate Warrants is expected to generate 22.51 times more return on investment than Enliven Therapeutics. However, Cingulate Warrants is 22.51 times more volatile than Enliven Therapeutics. It trades about 0.12 of its potential returns per unit of risk. Enliven Therapeutics is currently generating about 0.04 per unit of risk. If you would invest 20.00 in Cingulate Warrants on August 27, 2024 and sell it today you would lose (15.87) from holding Cingulate Warrants or give up 79.35% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Insignificant |
| Accuracy | 73.99% |
| Values | Daily Returns |
Cingulate Warrants vs. Enliven Therapeutics
Performance |
| Timeline |
| Cingulate Warrants |
| Enliven Therapeutics |
Cingulate Warrants and Enliven Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cingulate Warrants and Enliven Therapeutics
The main advantage of trading using opposite Cingulate Warrants and Enliven Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cingulate Warrants position performs unexpectedly, Enliven Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Enliven Therapeutics will offset losses from the drop in Enliven Therapeutics' long position.| Cingulate Warrants vs. Eliem Therapeutics | Cingulate Warrants vs. HCW Biologics | Cingulate Warrants vs. Scpharmaceuticals | Cingulate Warrants vs. Milestone Pharmaceuticals |
| Enliven Therapeutics vs. Capricor Therapeutics | Enliven Therapeutics vs. Soleno Therapeutics | Enliven Therapeutics vs. Bio Path Holdings | Enliven Therapeutics vs. Moleculin Biotech |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Insider Screener module to find insiders across different sectors to evaluate their impact on performance.
Other Complementary Tools
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA | |
| Stocks Directory Find actively traded stocks across global markets | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets |